Results 161 to 170 of about 1,780 (172)

USE OF mCRP TO ENHANCE IMMUNE RESPONSES

2000
POTEMPA LAWRENCE A, RADOSEVICH JAMES A
openaire   +4 more sources

Multimeric FHR4 immunoconjugates promote efficient activation of CAP on Her2 tumour cells, further controlled by overexpressed mCRPs, limiting MAC formation and CDC

Molecular Immunology, 2017
Jean-Marc Plesseria, Charlène Verschueren, Gilles Iserentant, Jacques H.M. Cohen, Carole Devaux, Xavier Dervillez   +5 more
openaire   +1 more source

Use of mCRP to slow cell growth and to promote maturation of cells

2000
POTEMPA LAWRENCE A, RADOSEVICH JAMES A
openaire   +3 more sources

USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS

2000
POTEMPA LAWRENCE A, RADOSEVICH JAMES A, DIEHL EDWARD E   +2 more
openaire   +1 more source

Native and modified C-reactive protein bind different receptors on human neutrophils

International Journal of Biochemistry and Cell Biology, 2005
Rita M Heuertz
exaly  

Cell membranes and liposomes dissociate C‐reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP m

FASEB Journal, 2007
Li Zhu, Shang-Rong Ji
exaly  

MCRP ANTAGONISTS AND THEIR USES

2008
openaire   +1 more source

The anti-mCRP199–206 antibodies aggravate tubulointerstitial lesions in lupus nephritis

Clinical Immunology
Mo Yuan, Ying Tan, Ming-Hui Zhao
exaly  

mCRP as a Biomarker of ANCA ‐Associated Vasculitis

International Journal of Rheumatic Diseases
Masaaki Fujita
exaly  

Spezifisches „Targeting“ von Tumorzellen: Zielgerichtete Expressionshemmung humaner membranständiger Komplement-regulatoren (mCRP) zur Überwindung der Komplementresistenz von CD71 hoch-exprimierenden Tumorzellen

2015
openaire   +1 more source